Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Neoplasms 3 Prostatic Neoplasms 2 Pain, Postoperative 2 Pain 2 Neuroma 2 Chronic Pain 2 Breast Diseases 2 Wounds and Injuries 1 Stroke 1 Stomach Neoplasms 1 Spinal Cord Injuries 1 Skin Diseases 1 Rectal Neoplasms 1 Prostatic Hyperplasia 1 Pancreatic Neoplasms 1 Neoplasms by Site 1 Muscular Atrophy 1 Muscle Spasticity 1 Lower Urinary Tract Symptoms 1 Low Anterior Resection Syndrome 1 Hereditary leiomyomatosis and renal cell cancer 1 Head and Neck Neoplasms 1 Gastroparesis 1 Ganglion Cysts 1 Esophageal Neoplasms 1 Esophageal Motility Disorders 1 Esophageal Diseases 1 Esophageal Achalasia 1 Cluster Headache 1

Interventions

Bupivacaine 11 Ketamine 9 Ropivacaine 8 Morphine 8 Analgesics, Opioid 8 Acetaminophen 8 Fentanyl 7 Dexmedetomidine 7 Lidocaine 6 Anesthesia, General 6 Saline Solution 5 Anesthesia, Local 5 Acupuncture Therapy 5 parecoxib 4 Tramadol 4 Surveys and Questionnaires 4 Sodium Chloride 4 Pregabalin 4 Ethanol 4 Analgesia, Epidural 4 Transcutaneous Electric Nerve Stimulation 3 Radiofrequency Ablation 3 Propofol 3 Oxycodone 3 Ketorolac 3 Control Groups 3 Anesthetics, Local 3 trimebutine 3-thiocarbamoylbenzenesulfonate 2 Therapeutics 2 Tea 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Agnosia × Botulinum Toxins, Type A × Clear all

NCT06807164 2026-03-27

SerCaBot

Centre Oscar Lambret

Phase 2 Recruiting

Agnosia, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡